A blocking experiment was performed providing further support for highly selective CEA targeting in vivo, demonstrating a large reduction in the tumor signal BxPC3 xenografts when injection of [99mTc]Tc-C9-C9 was done one hour after injection of a 100-fold excess of non-labeled C9-C9 (Fig. 9). This evidence concerns the gene C9 and neoplasm.